DA32 Life Science Tech Acquisition Corp.

CIK: 1863294•Ticker: DALS

SPAC Overview

$200M

IPO Size

Failed

Current Status

2021

IPO Year

Timeline Progress

Investment Focus

Life Sciences

SPAC Team

Sponsors

Leadership

Chief Executive Officer and Director

Andrew ElBardissi

Kevin Hrusovsky

Christopher Wolfe

Chief Financial Officer and Secretary

Underwriters

J.P. Morgan Securities Cowen and Company

Key Information

IPO Date

July 29, 2021

Completion Date

August 7, 2023

SPAC Ticker

DALS

External Resources

View Detailed Analysis